Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Year-over-year net income growth rate
3Y CAGR
-28.7%/yr
vs +142.7%/yr prior
Acceleration
-171.3pp
Decelerating
Percentile
P82
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 30.48% |
| Q3 2025 | 8.80% |
| Q2 2025 | 1.38% |
| Q1 2025 | -2.47% |
| Q4 2024 | 6.49% |
| Q3 2024 | 2.26% |
| Q2 2024 | 6.61% |
| Q1 2024 | -0.67% |
| Q4 2023 | -1.98% |
| Q3 2023 | -30.64% |
| Q2 2023 | 34.91% |
| Q1 2023 | -3.29% |
| Q4 2022 | 83.98% |
| Q3 2022 | -464.19% |
| Q2 2022 | -56.79% |
| Q1 2022 | 37.80% |
| Q4 2021 | 1.92% |
| Q3 2021 | -21.91% |
| Q2 2021 | 29.53% |
| Q1 2021 | -48.46% |
| Q4 2020 | -1.95% |
| Q3 2020 | -180.74% |
| Q2 2020 | 265.36% |
| Q1 2020 | 19.49% |
| Q4 2019 | -1.18% |
| Q3 2019 | 4.71% |
| Q2 2019 | -17.70% |
| Q1 2019 | -22.74% |
| Q4 2018 | -0.23% |
| Q3 2018 | 12.90% |
| Q2 2018 | 18.19% |
| Q1 2018 | -74.01% |
| Q4 2017 | 16.48% |
| Q3 2017 | -108.85% |
| Q2 2017 | 513.66% |
| Q1 2017 | -57.10% |
| Q4 2016 | 13.44% |
| Q3 2016 | 12.15% |
| Q2 2016 | 34.60% |
| Q1 2016 | 63.91% |